Cancer Science,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 2, 2025
ABSTRACT
Cancer‐associated
fibroblasts
(CAFs)
are
key
components
of
the
tumor
microenvironment
(TME).
Given
their
various
roles
in
progression
and
treatment
resistance,
CAFs
promising
therapeutic
targets
cancer.
The
elimination
tumor‐promoting
has
been
investigated
animal
models
to
determine
whether
it
effectively
suppresses
growth.
Based
on
recent
evidence,
several
simple
strategies
have
proposed
eliminate
attenuate
these
features.
In
addition,
attention
focused
critical
role
that
play
immunosuppressive
TME.
Therefore,
functional
reprogramming
combination
with
immune
checkpoint
inhibitors
also
as
a
possible
approach.
However,
although
potential
widely
characterized,
plasticity
heterogeneity
complicate
understanding
properties
present
difficulties
for
clinical
application.
Moreover,
identification
tumor‐suppressive
highlights
necessity
development
approaches
can
distinguish
switch
between
an
appropriate
manner.
this
review,
we
introduce
origins
diversity
CAFs,
cancer,
current
aimed
at
targeting
including
ongoing
evaluations.
Molecular Cancer,
Journal Year:
2023,
Volume and Issue:
22(1)
Published: June 15, 2023
Abstract
Background
Cancer
is
the
most
prevalent
cause
of
death
globally,
and
radiotherapy
considered
standard
care
for
solid
tumors,
including
lung,
breast,
esophageal,
colorectal
cancers
glioblastoma.
Resistance
to
radiation
can
lead
local
treatment
failure
even
cancer
recurrence.
Main
body
In
this
review,
we
have
extensively
discussed
several
crucial
aspects
that
resistance
therapy,
radiation-induced
DNA
damage
repair,
cell
cycle
arrest,
apoptosis
escape,
abundance
stem
cells,
modification
cells
their
microenvironment,
presence
exosomal
non-coding
RNA,
metabolic
reprogramming,
ferroptosis.
We
aim
focus
on
molecular
mechanisms
in
relation
these
discuss
possible
targets
improve
outcomes.
Conclusions
Studying
responsible
its
interactions
with
tumor
environment
will
help
responses
radiotherapy.
Our
review
provides
a
foundation
identify
overcome
obstacles
effective
Gut,
Journal Year:
2023,
Volume and Issue:
72(9), P. 1774 - 1782
Published: Jan. 27, 2023
Investigating
the
effect
of
ferroptosis
in
tumour
microenvironment
to
identify
combinatory
therapy
for
liver
cancer
treatment.Glutathione
peroxidase
4
(GPx4),
which
is
considered
master
regulator
ferroptosis,
was
genetically
altered
murine
models
hepatocellular
carcinoma
(HCC)
and
colorectal
(CRC)
analyse
on
cells
immune
microenvironment.
The
findings
served
as
foundation
identification
additional
targets
combine
with
ferroptotic
inducer
treatment
HCC
metastasis.Surprisingly,
hepatocyte-restricted
GPx4
loss
does
not
suppress
tumourigenesis.
Instead,
GPx4-associated
hepatocyte
death
causes
a
suppressive
response
characterised
by
CXCL10-dependent
infiltration
cytotoxic
CD8+
T
that
counterbalanced
PD-L1
upregulation
well
marked
HMGB1-mediated
myeloid
derived
suppressor
cell
(MDSC)
infiltration.
Blocking
PD-1
or
HMGB1
unleashes
activation
prolongs
survival
mice
Gpx4-deficient
tumours.
A
triple
combination
inducing
natural
compound
withaferin
A,
CXCR2
inhibitor
SB225002
α-PD-1
greatly
improves
wild-type
In
contrast,
same
affect
growth
subcutaneously
grown
CRC
organoids,
while
it
decreases
their
metastatic
liver.Our
data
highlight
context-specific
ferroptosis-induced
could
be
therapeutically
exploited
primary
tumours
metastases.
Clinical Cancer Research,
Journal Year:
2022,
Volume and Issue:
29(6), P. 1009 - 1016
Published: Nov. 18, 2022
Abstract
Tumor-associated
inflammation
(TAI)
is
a
feature
of
essentially
all
cancers
and
can
confer
both
tumor-promoting
-suppressive
functions.
Cancer-associated
fibroblasts
(CAF)
comprise
one
very
heterogeneous
cellular
component
the
tumor
microenvironment
characterized
by
high
degree
plasticity.
Recent
single-cell
sequencing
analyses
revealed
distinct
CAF
populations
in
various
human
helped
to
define
key
subtypes,
such
as
myofibroblastic,
inflammatory,
antigen-presenting
CAFs,
with
first
two
being
present
virtually
tumors.
Importantly,
these
three
are
involved
modulate
positive
negative
consequences
TAI.
The
remarkable
plasticity
CAFs
allows
them
shift
phenotypically
functionally
response
environmental
changes.
In
this
review,
we
describe
how
nurture
suppress
adaptive
immunity.
We
also
summarize
recently
emerging
evidence
pertaining
tumor-suppressive
functions
context
Finally,
therapeutic
concepts
that
aim
at
modulating
or
depleting
immunosuppressive
synergize
immunotherapy.
Molecular Oncology,
Journal Year:
2022,
Volume and Issue:
16(18), P. 3333 - 3351
Published: June 8, 2022
The
senescence-associated
secretory
phenotype
(SASP),
where
senescent
cells
produce
a
variety
of
secreted
proteins
including
inflammatory
cytokines,
chemokines,
matrix
remodelling
factors,
growth
factors
and
so
on,
plays
pivotal
but
varying
roles
in
the
tumour
microenvironment.
effects
SASP
on
surrounding
microenvironment
depend
cell
type
process
cellular
senescence
induction,
which
is
often
associated
with
innate
immunity.
Via
SASP-mediated
paracrine
effects,
can
remodel
tissues
by
modulating
character
adjacent
cells,
such
as
stromal,
immune
well
cancer
cells.
both
tumour-suppressive
tumour-promoting
observed
surveillance
(tumour-suppressive)
suppression
anti-tumour
immunity
most
cancer-associated
fibroblasts
T
(tumour-promoting).
In
this
review,
we
discuss
features
emphasis
their
context-dependency
that
determines
whether
they
promote
or
suppress
development.
Potential
usage
recently
developed
drugs
(senomorphics)
selectively
kill
(senolytics)
therapy
are
also
discussed.
Advanced Science,
Journal Year:
2022,
Volume and Issue:
9(29)
Published: Aug. 19, 2022
The
effective
treatment
of
advanced
cervical
cancer
remains
challenging.
Herein,
single-nucleus
RNA
sequencing
(snRNA-seq)
and
SpaTial
enhanced
resolution
omics-sequencing
(Stereo-seq)
are
used
to
investigate
the
immunological
microenvironment
squamous
cell
carcinoma
(CSCC).
expression
levels
most
immune
suppressive
genes
in
tumor
inflammation
areas
CSCC
not
significantly
higher
than
those
non-cancer
samples,
except
for
LGALS9
IDO1.
Stronger
signals
CD56
Immunity,
Journal Year:
2022,
Volume and Issue:
55(11), P. 2059 - 2073.e8
Published: Oct. 19, 2022
T
memory
stem
cells
(TSCM)
display
increased
self-renewal
and
prolonged
survival
capabilities,
thus
preventing
cell
exhaustion
promoting
effective
anti-tumor
responses.
TSCM
can
be
expanded
by
Urolithin
A
(UA),
which
is
produced
the
commensal
gut
microbiome
from
foods
rich
in
ellagitannins
known
to
improve
mitochondrial
health.
Oral
UA
administration
tumor-bearing
mice
conferred
strong
CD8+
immunity,
whereas
ex
vivo
pre-treated
displayed
improved
function
upon
adoptive
transfer.
UA-induced
formation
depended
on
Pink1-mediated
mitophagy
triggering
cytosolic
release
of
phosphatase
Pgam5.
Cytosolic
Pgam5
dephosphorylated
β-catenin,
drove
Wnt
signaling
compensatory
biogenesis.
Collectively,
we
unravel
a
critical
pathway
linking
suggest
that
well-tolerated
metabolic
compound
represents
an
attractive
option
immune
therapy.
Cancer Research,
Journal Year:
2023,
Volume and Issue:
83(10), P. 1596 - 1610
Published: March 13, 2023
Abstract
Cancer-associated
fibroblasts
(CAF)
are
a
major
cell
type
in
the
stroma
of
solid
tumors
and
can
exert
both
tumor-promoting
tumor-restraining
functions.
CAF
heterogeneity
is
frequently
observed
pancreatic
ductal
adenocarcinoma
(PDAC),
tumor
characterized
by
dense
hypoxic
that
features
myofibroblastic
CAFs
(myCAF)
inflammatory
(iCAF)
thought
to
have
opposing
roles
progression.
While
be
driven
part
cell–produced
cytokines,
other
determinants
shaping
identity
function
largely
unknown.
In
vivo,
we
found
iCAFs
displayed
gene
expression
biochemical
profile
were
enriched
regions
PDAC
tumors,
while
myCAFs
excluded
from
these
regions.
Hypoxia
led
acquire
an
signature
synergized
with
cancer
cell–derived
cytokines
promote
iCAF
phenotype
HIF1α-dependent
fashion.
Furthermore,
HIF1α
stabilization
was
sufficient
induce
stromal
cells
introduced
into
organoid
cocultures
growth.
These
findings
indicate
hypoxia-induced
as
regulator
promoter
progression
PDAC.
Significance:
microenvironment
potentiates
cytokine-induced
promotes
See
related
commentary
Fuentes
Taniguchi,
p.
1560